DENNER ALEXANDER J 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Apr 4, 2025
Insider Transaction Report
Form 4
Denner Alexander J
Director10% Owner
Transactions
- Award
Class A Common Stock
2025-04-02+10,416→ 166,769 total
Holdings
- 16,390,000(indirect: See Footnote)
Class A Common Stock
Footnotes (2)
- [F1]Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024.
- [F2]Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which SarissaCapital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of theSarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of SarissaCapital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein.